Literature DB >> 17022848

Assessing the total costs of blood delivery to hospital oncology and haematology patients.

Samir Agrawal1, Neville Davidson, Mel Walker, Sian Gibson, Christina Lim, Christopher Ll Morgan, Warren Cowell.   

Abstract

OBJECTIVE: To determine direct costs associated with a blood transfusion session in two hospital settings. RESEARCH DESIGN AND METHODS: The study was conducted in two United Kingdom hospital sites during April 2004. Transfusion sessions for patients receiving units of red blood cells within either haematology or oncology departments were followed using time and motion techniques to measure the direct costs. Other data were collected from the centres to calculate the cost of disposables, blood wastage and blood bank machines.
RESULTS: Total mean staff cost per transfusion of 2 units was 37.24 pounds sterling (9.68 pounds sterling for blood bank and 27.56 pounds sterling for ward procedures). The mean cost of disposables was 13.25 pounds sterling and the mean cost for blood products was 287.56 pounds sterling. The mean cost of wastage was 11.86 pounds sterling per transfusion. After including other derived costs, such as hospital stay, the mean cost for a transfusion of 2 units of blood was estimated to be 546.12 pounds sterling.
CONCLUSION: This study estimates the cost of an average blood transfusion of 2 units to be 546.12 pounds sterling. It should be noted that significant indirect costs, such as those incurred by patients, their carers and societal costs, have not been considered. Against the background of finite blood resources and other factors such as patient quality of life, blood transfusion may not represent the best choice for patient care. Alternative treatments should be considered.

Entities:  

Mesh:

Year:  2006        PMID: 17022848     DOI: 10.1185/030079906X132532

Source DB:  PubMed          Journal:  Curr Med Res Opin        ISSN: 0300-7995            Impact factor:   2.580


  3 in total

Review 1.  Asthma outcomes: healthcare utilization and costs.

Authors:  Lara J Akinbami; Sean D Sullivan; Jonathan D Campbell; Robert W Grundmeier; Tina V Hartert; Todd A Lee; Robert A Smith
Journal:  J Allergy Clin Immunol       Date:  2012-03       Impact factor: 10.793

2.  Blood component use and associated costs after standard dose chemotherapy--a prospective analysis of routine hospital care in lymphoproliferative disorders and NSCLC in Germany.

Authors:  Bernadette Paessens; Angela Ihbe-Heffinger; Christoph von Schilling; Rita Shlaen; Rudolf Bernard; Christian Peschel; Wolfgang Schramm; Karin Berger
Journal:  Support Care Cancer       Date:  2011-05-12       Impact factor: 3.603

Review 3.  Hemoglobin level at initiation of darbepoetin alfa: impact on need for transfusion and associated costs in chemotherapy-induced anemia treatment in Europe.

Authors:  Melike Deger; Wolfgang Eisterer; Lucie Kutikova; Sam Salek
Journal:  Support Care Cancer       Date:  2012-07-24       Impact factor: 3.603

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.